NEW YORK (GenomeWeb News) – Reagents maker Link Technologies said today that it will sell RiboTask's nucleic acid monomers, under a new license agreement.

Link, a Scottish company, will make and commercialize RiboTask's unlocked-nucleic acid (UNA) monomer phosphoramadite reagents, which are used to enable fine-tuning of oligonucleotide stability in siRNA gene silencing and other applications.

Patents for the therapeutic use of UNA oligonucleotides are held by MDRNA, according to Link.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.